Robert Byington to Thiazolidinediones
This is a "connection" page, showing publications Robert Byington has written about Thiazolidinediones.
Connection Strength
0.101
-
Linz PE, Lovato LC, Byington RP, O'Connor PJ, Leiter LA, Weiss D, Force RW, Crouse JR, Ismail-Beigi F, Simmons DL, Papademetriou V, Ginsberg HN, Elam MB. Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. Diabetes Care. 2014; 37(3):686-93.
Score: 0.101